[
  {
    "title": "Divis Laboratories Inks Supply Pact With Global Pharmaceutical Entity - NDTV Profit",
    "link": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxNSVBjclhHVHVQd2hBWXdEZE53VmMwMnV3Q0RIN2tnU3ZTS21nTUdLTkpCNFc3clF0ejhXeHhxRkxacXRkRF9YQXp4WXp2cDRwNm5NNWVWOFJKUk9MQXdFOWZJQ0ZTN3lSSmJoUWZBbG4zTFNkeDlLMDVPTlpNNThta1VYcDBmRmRZTU1uOGJoMTdLT3ZYZjNiNFpxdXNNRk0wV1ozamFzaUrSAa4BQVVfeXFMTjVxUVl1OTdyaC1QRXlMSk5lSTNZYmJYQlVjR1QxQjdNQnB5X1dGN3B6T2lOY3djV2lxMEJ0VTVxWlBCLXdhSE05TGMyNUl6Q3N3VWkydlhUdGFjTkIxQnFPVXFLN0lGVTFPZHNqdkN5MVhBLU1UZ3ljUmtmQ1hxdnFwQkxmSG9JRVd3UW0yNmJ4Mkk0RzJfdnlERXF0bFBZbHN3UHNYOHl1RzZfYUxB?oc=5",
    "published": "Fri, 18 Apr 2025 07:00:00 GMT",
    "summary": "<a href=\"https://news.google.com/rss/articles/CBMiqAFBVV95cUxNSVBjclhHVHVQd2hBWXdEZE53VmMwMnV3Q0RIN2tnU3ZTS21nTUdLTkpCNFc3clF0ejhXeHhxRkxacXRkRF9YQXp4WXp2cDRwNm5NNWVWOFJKUk9MQXdFOWZJQ0ZTN3lSSmJoUWZBbG4zTFNkeDlLMDVPTlpNNThta1VYcDBmRmRZTU1uOGJoMTdLT3ZYZjNiNFpxdXNNRk0wV1ozamFzaUrSAa4BQVVfeXFMTjVxUVl1OTdyaC1QRXlMSk5lSTNZYmJYQlVjR1QxQjdNQnB5X1dGN3B6T2lOY3djV2lxMEJ0VTVxWlBCLXdhSE05TGMyNUl6Q3N3VWkydlhUdGFjTkIxQnFPVXFLN0lGVTFPZHNqdkN5MVhBLU1UZ3ljUmtmQ1hxdnFwQkxmSG9JRVd3UW0yNmJ4Mkk0RzJfdnlERXF0bFBZbHN3UHNYOHl1RzZfYUxB?oc=5\" target=\"_blank\">Divis Laboratories Inks Supply Pact With Global Pharmaceutical Entity</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">NDTV Profit</font>",
    "stock_symbol": "GLENMARK.NSE",
    "search_date": "2025-04-18",
    "search_query": "GLENMARK stock news 2025-04-18"
  }
]